Cancer Therapy: Low‐Dose Prostate Cancer Brachytherapy with Radioactive Palladium–Gold Nanoparticles (Adv. Healthcare Mater. 4/2017)

Prostate cancer is often treated by internal radiotherapy (brachytherapy), by which tens of radioactive implants made of massive metal « seeds » are inserted in the diseased tissue. Article number 1601120 by Marc‐André Fortin and co‐workers, reports on a new technology based on the injection of radi...

Full description

Saved in:
Bibliographic Details
Published in:Advanced healthcare materials 2017-02, Vol.6 (4), p.np-n/a
Main Authors: Laprise‐Pelletier, Myriam, Lagueux, Jean, Côté, Marie‐France, LaGrange, Thomas, Fortin, Marc‐André
Format: Article
Language:English
Subjects:
alginate
intratumoral injections
low‐dose brachytherapy
palladium–gold nanoparticles
prostate cancer
radioactive gold nanoparticles
radioactive palladium
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page n/a
container_issue 4
container_start_page np
container_title Advanced healthcare materials
container_volume 6
creator Laprise‐Pelletier, Myriam
Lagueux, Jean
Côté, Marie‐France
LaGrange, Thomas
Fortin, Marc‐André
description Prostate cancer is often treated by internal radiotherapy (brachytherapy), by which tens of radioactive implants made of massive metal « seeds » are inserted in the diseased tissue. Article number 1601120 by Marc‐André Fortin and co‐workers, reports on a new technology based on the injection of radioactive gold nanoparticles. The nanoparticles diffuse into the tumour, where they progressively deliver a radiotherapeutic dose more precisely and with fewer potential side‐effects.
doi_str_mv 10.1002/adhm.201770018
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1877836028</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4316560671</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1908-3af01947221985feeac5fe54f8d8eec5c1d7d583b6c2e9a6fb16b4911c08bae63</originalsourceid><addsrcrecordid>eNqFkcFPwjAUxhejiQS5em7iBQ-Mdmxd5w1BwQTUGDwvj-4tGxkU2w3CjaNHE_9D_hJLIJh48R36XpPf9_K1n-NcM-oySr02JNnc9SgLQ0qZOHNqHou8lseD6Pw0-_TSaRgzo7Z4wLhgNeezBwuJmkwy1LDc3JGRWu-2X31lkLxqZUookRyZew0y25QHkqzzMiNvkOQKZJmvLA5FYa_VfLf9HqgiIc-wUEvQZS4LNKTZTVYuGSIUZSZBIxnb1dolfntv-_bKuUihMNg49rrz_vgw6Q1bo5fBU687akkWUdHqQEpZ5IeefZMIUkSQ9gz8VCQCUQaSJWESiM6USw8j4OmU8akfMSapmALyTt1pHvYutfqo0JTxPDcSrfUFqsrETISh6HDqCYve_EFnqtIL625PUW4pQS3lHihpv8toTOOlzuegNzGj8T6beJ9NfMrGCqKDYJ0XuPmHjrv94fhX-wNGa5RB</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1870636080</pqid></control><display><type>article</type><title>Cancer Therapy: Low‐Dose Prostate Cancer Brachytherapy with Radioactive Palladium–Gold Nanoparticles (Adv. Healthcare Mater. 4/2017)</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Laprise‐Pelletier, Myriam ; Lagueux, Jean ; Côté, Marie‐France ; LaGrange, Thomas ; Fortin, Marc‐André</creator><creatorcontrib>Laprise‐Pelletier, Myriam ; Lagueux, Jean ; Côté, Marie‐France ; LaGrange, Thomas ; Fortin, Marc‐André</creatorcontrib><description>Prostate cancer is often treated by internal radiotherapy (brachytherapy), by which tens of radioactive implants made of massive metal « seeds » are inserted in the diseased tissue. Article number 1601120 by Marc‐André Fortin and co‐workers, reports on a new technology based on the injection of radioactive gold nanoparticles. The nanoparticles diffuse into the tumour, where they progressively deliver a radiotherapeutic dose more precisely and with fewer potential side‐effects.</description><identifier>ISSN: 2192-2640</identifier><identifier>EISSN: 2192-2659</identifier><identifier>DOI: 10.1002/adhm.201770018</identifier><language>eng</language><publisher>Weinheim: Wiley Subscription Services, Inc</publisher><subject>alginate ; intratumoral injections ; low‐dose brachytherapy ; palladium–gold nanoparticles ; prostate cancer ; radioactive gold nanoparticles ; radioactive palladium</subject><ispartof>Advanced healthcare materials, 2017-02, Vol.6 (4), p.np-n/a</ispartof><rights>2017 WILEY‐VCH Verlag GmbH &amp; Co. KGaA, Weinheim</rights><rights>2017 WILEY-VCH Verlag GmbH &amp; Co. KGaA, Weinheim</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids></links><search><creatorcontrib>Laprise‐Pelletier, Myriam</creatorcontrib><creatorcontrib>Lagueux, Jean</creatorcontrib><creatorcontrib>Côté, Marie‐France</creatorcontrib><creatorcontrib>LaGrange, Thomas</creatorcontrib><creatorcontrib>Fortin, Marc‐André</creatorcontrib><title>Cancer Therapy: Low‐Dose Prostate Cancer Brachytherapy with Radioactive Palladium–Gold Nanoparticles (Adv. Healthcare Mater. 4/2017)</title><title>Advanced healthcare materials</title><description>Prostate cancer is often treated by internal radiotherapy (brachytherapy), by which tens of radioactive implants made of massive metal « seeds » are inserted in the diseased tissue. Article number 1601120 by Marc‐André Fortin and co‐workers, reports on a new technology based on the injection of radioactive gold nanoparticles. The nanoparticles diffuse into the tumour, where they progressively deliver a radiotherapeutic dose more precisely and with fewer potential side‐effects.</description><subject>alginate</subject><subject>intratumoral injections</subject><subject>low‐dose brachytherapy</subject><subject>palladium–gold nanoparticles</subject><subject>prostate cancer</subject><subject>radioactive gold nanoparticles</subject><subject>radioactive palladium</subject><issn>2192-2640</issn><issn>2192-2659</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNqFkcFPwjAUxhejiQS5em7iBQ-Mdmxd5w1BwQTUGDwvj-4tGxkU2w3CjaNHE_9D_hJLIJh48R36XpPf9_K1n-NcM-oySr02JNnc9SgLQ0qZOHNqHou8lseD6Pw0-_TSaRgzo7Z4wLhgNeezBwuJmkwy1LDc3JGRWu-2X31lkLxqZUookRyZew0y25QHkqzzMiNvkOQKZJmvLA5FYa_VfLf9HqgiIc-wUEvQZS4LNKTZTVYuGSIUZSZBIxnb1dolfntv-_bKuUihMNg49rrz_vgw6Q1bo5fBU687akkWUdHqQEpZ5IeefZMIUkSQ9gz8VCQCUQaSJWESiM6USw8j4OmU8akfMSapmALyTt1pHvYutfqo0JTxPDcSrfUFqsrETISh6HDqCYve_EFnqtIL625PUW4pQS3lHihpv8toTOOlzuegNzGj8T6beJ9NfMrGCqKDYJ0XuPmHjrv94fhX-wNGa5RB</recordid><startdate>20170201</startdate><enddate>20170201</enddate><creator>Laprise‐Pelletier, Myriam</creator><creator>Lagueux, Jean</creator><creator>Côté, Marie‐France</creator><creator>LaGrange, Thomas</creator><creator>Fortin, Marc‐André</creator><general>Wiley Subscription Services, Inc</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7QF</scope><scope>7QP</scope><scope>7QQ</scope><scope>7SC</scope><scope>7SE</scope><scope>7SP</scope><scope>7SR</scope><scope>7T5</scope><scope>7TA</scope><scope>7TB</scope><scope>7TM</scope><scope>7TO</scope><scope>7U5</scope><scope>8BQ</scope><scope>8FD</scope><scope>F28</scope><scope>FR3</scope><scope>H8D</scope><scope>H8G</scope><scope>H94</scope><scope>JG9</scope><scope>JQ2</scope><scope>K9.</scope><scope>KR7</scope><scope>L7M</scope><scope>L~C</scope><scope>L~D</scope><scope>7QO</scope><scope>P64</scope></search><sort><creationdate>20170201</creationdate><title>Cancer Therapy: Low‐Dose Prostate Cancer Brachytherapy with Radioactive Palladium–Gold Nanoparticles (Adv. Healthcare Mater. 4/2017)</title><author>Laprise‐Pelletier, Myriam ; Lagueux, Jean ; Côté, Marie‐France ; LaGrange, Thomas ; Fortin, Marc‐André</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1908-3af01947221985feeac5fe54f8d8eec5c1d7d583b6c2e9a6fb16b4911c08bae63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>alginate</topic><topic>intratumoral injections</topic><topic>low‐dose brachytherapy</topic><topic>palladium–gold nanoparticles</topic><topic>prostate cancer</topic><topic>radioactive gold nanoparticles</topic><topic>radioactive palladium</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Laprise‐Pelletier, Myriam</creatorcontrib><creatorcontrib>Lagueux, Jean</creatorcontrib><creatorcontrib>Côté, Marie‐France</creatorcontrib><creatorcontrib>LaGrange, Thomas</creatorcontrib><creatorcontrib>Fortin, Marc‐André</creatorcontrib><collection>CrossRef</collection><collection>Aluminium Industry Abstracts</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Ceramic Abstracts</collection><collection>Computer and Information Systems Abstracts</collection><collection>Corrosion Abstracts</collection><collection>Electronics &amp; Communications Abstracts</collection><collection>Engineered Materials Abstracts</collection><collection>Immunology Abstracts</collection><collection>Materials Business File</collection><collection>Mechanical &amp; Transportation Engineering Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Solid State and Superconductivity Abstracts</collection><collection>METADEX</collection><collection>Technology Research Database</collection><collection>ANTE: Abstracts in New Technology &amp; Engineering</collection><collection>Engineering Research Database</collection><collection>Aerospace Database</collection><collection>Copper Technical Reference Library</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Materials Research Database</collection><collection>ProQuest Computer Science Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Civil Engineering Abstracts</collection><collection>Advanced Technologies Database with Aerospace</collection><collection>Computer and Information Systems Abstracts – Academic</collection><collection>Computer and Information Systems Abstracts Professional</collection><collection>Biotechnology Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Advanced healthcare materials</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Laprise‐Pelletier, Myriam</au><au>Lagueux, Jean</au><au>Côté, Marie‐France</au><au>LaGrange, Thomas</au><au>Fortin, Marc‐André</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cancer Therapy: Low‐Dose Prostate Cancer Brachytherapy with Radioactive Palladium–Gold Nanoparticles (Adv. Healthcare Mater. 4/2017)</atitle><jtitle>Advanced healthcare materials</jtitle><date>2017-02-01</date><risdate>2017</risdate><volume>6</volume><issue>4</issue><spage>np</spage><epage>n/a</epage><pages>np-n/a</pages><issn>2192-2640</issn><eissn>2192-2659</eissn><abstract>Prostate cancer is often treated by internal radiotherapy (brachytherapy), by which tens of radioactive implants made of massive metal « seeds » are inserted in the diseased tissue. Article number 1601120 by Marc‐André Fortin and co‐workers, reports on a new technology based on the injection of radioactive gold nanoparticles. The nanoparticles diffuse into the tumour, where they progressively deliver a radiotherapeutic dose more precisely and with fewer potential side‐effects.</abstract><cop>Weinheim</cop><pub>Wiley Subscription Services, Inc</pub><doi>10.1002/adhm.201770018</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2192-2640
ispartof Advanced healthcare materials, 2017-02, Vol.6 (4), p.np-n/a
issn 2192-2640
2192-2659
language eng
recordid cdi_proquest_miscellaneous_1877836028
source Wiley-Blackwell Read & Publish Collection
subjects alginate
intratumoral injections
low‐dose brachytherapy
palladium–gold nanoparticles
prostate cancer
radioactive gold nanoparticles
radioactive palladium
title Cancer Therapy: Low‐Dose Prostate Cancer Brachytherapy with Radioactive Palladium–Gold Nanoparticles (Adv. Healthcare Mater. 4/2017)
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T21%3A40%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cancer%20Therapy:%20Low%E2%80%90Dose%20Prostate%20Cancer%20Brachytherapy%20with%20Radioactive%20Palladium%E2%80%93Gold%20Nanoparticles%20(Adv.%20Healthcare%20Mater.%204/2017)&rft.jtitle=Advanced%20healthcare%20materials&rft.au=Laprise%E2%80%90Pelletier,%20Myriam&rft.date=2017-02-01&rft.volume=6&rft.issue=4&rft.spage=np&rft.epage=n/a&rft.pages=np-n/a&rft.issn=2192-2640&rft.eissn=2192-2659&rft_id=info:doi/10.1002/adhm.201770018&rft_dat=%3Cproquest_cross%3E4316560671%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c1908-3af01947221985feeac5fe54f8d8eec5c1d7d583b6c2e9a6fb16b4911c08bae63%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1870636080&rft_id=info:pmid/&rfr_iscdi=true